Advertisement

Topics

Genzyme Corporation Company Profile

23:58 EDT 19th September 2017 | BioPortfolio

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 12,000 employees in locations spanning the globe and 2009 revenues of $4.5 billion. In 2010, Genzyme was named to the Fortune 500.


News Articles [134 Associated News Articles listed on BioPortfolio]

STAT Plus: New chief aims to remake Sanofi Genzyme

Sanofi Genzyme's new president, Bill Sibold, is the first one without any ties to the old Genzyme, which pioneered the rare-disease business model.

Family, friends recall contributions of former Genzyme executive Henri Termeer

Hundreds gathered on the MIT campus Saturday morning to celebrate the life of Henri Termeer, the former Genzyme Corp. chief executive who oversaw the company's growth from a small local firm to a ...

Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer

Henri Termeer, a biotechnology pioneer and the longtime CEO of Genzyme, has passed away at the age of 71. According to the Boston Globe, Termeer collapsed in his home in Marblehead, MA, on Friday nigh...

Sanofi Genzyme Reports Results From Phase 2 Open-Label Extension Study

PARIS (dpa-AFX) - Sanofi Genzyme, the specialty care global business unit of Sanofi (SNYNF), and Alnylam Pharmaceuticals, Inc announced new positive results from the ongoing phase 2 open-label ext...

Alnylam and Sanofi Genzyme to Present New Clinical Trial Results at the International Society of Thrombosis and Haemostasis (ISTH) Congress

Monday, June 26th 2017 at 8:01pm UTC – New Data from an Ongoing Phase 2 Open-label Extension Study with Fitusiran in Patients with Hemophilia A and B, With or Without Inhibitors– CAMBRIDGE, Mass.&...

Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 01052017] Prices from USD $350

Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

Biotech loses pioneer Henri Termeer

Friday, May 12th, Genzyme founder Henri Termeer passed at age 71. Termeer led Genzyme of almost 30 years. He rose to CEO shortly before its acquisition by Sanofi in 2011. Many in the industry credit T...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant.

Graft-versus-host disease (GVHD) is a leading cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (alloHCT). Prophylactic in-vivo T-Cell depletion with antithymocyte...

Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.

Deficiency of glucocerebrosidase (GBA) causes Gaucher disease (GD). In the common non-neuronopathic GD type I variant, glucosylceramide accumulates primarily in the lysosomes of visceral macrophages. ...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

Extension Study of Long-Term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

This extension study was to monitor the long-term safety and efficacy of rhGAA treatment in a single patient with infantile-onset Pompe disease who were previously treated with rhGAA in a ...

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

This open-label, rater-blinded extension study will enroll patients who have relapsing-remitting multiple sclerosis (RRMS) and who participated in one of three prior Genzyme-sponsored stud...

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

This study is sponsored by Genzyme Japan K.K. The purpose of this study is to assess the safety, tolerability and pharmacokinetics of Clofarabine (JC0707) intravenously administered to Jap...

Comparison of ATG to Thymoglobuline in Renal Transplantation

An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Freseni...

Companies [190 Associated Companies listed on BioPortfolio]

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact o...

Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals t...

Genzyme Corp.

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company ha...

Genzyme Genetics

Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services. As a business unit of Genzyme Corporation, Genzyme Genetics em...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

More Information about "Genzyme Corporation" on BioPortfolio

We have published hundreds of Genzyme Corporation news stories on BioPortfolio along with dozens of Genzyme Corporation Clinical Trials and PubMed Articles about Genzyme Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genzyme Corporation Companies in our database. You can also find out about relevant Genzyme Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record